Cargando…

Life expectancy in patients with inflammatory bowel disease: time will tell if biologics are the answer

Detalles Bibliográficos
Autores principales:	Chanchlani, Neil, Russell, Richard K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Joule Inc. 2021
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096403/ https://www.ncbi.nlm.nih.gov/pubmed/33722831 http://dx.doi.org/10.1503/cmaj.78144

Ejemplares similares

Worms and the Treatment of Inflammatory Bowel Disease: Are Molecules the Answer?
por: Ruyssers, Nathalie E., et al.
Publicado: (2008)

Satisfaction and expectations of patients with inflammatory bowel disease on biologic therapy: a multicenter study
por: Guarini, Alessandra, et al.
Publicado: (2017)

Cancer patients’ willingness to answer survey questions about life expectancy
por: Mackenzie, L. J., et al.
Publicado: (2012)

Patient-reported healthcare expectations in inflammatory bowel diseases
por: Pittet, Valérie, et al.
Publicado: (2018)

Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic
por: Lin, Simeng, et al.
Publicado: (2022)

Hemolytic Anemia in Inflammatory Bowel Disease: Our “Gut” Tells Us to Blame the Drug
por: Berger, Matthew, et al.
Publicado: (2021)

The optimal time to perform an ophthalmic examination of patients with inflammatory bowel disease
por: Biancardi, Ana Luiza, et al.
Publicado: (2019)

Lung involvement in inflammatory bowel diseases
por: Sarıoğlu, Nurhan, et al.
Publicado: (2006)

Predictive approaches in inflammatory bowel disease
por: Pinton, Philippe
Publicado: (2021)

P-glycoprotein multidrug transporter in inflammatory bowel diseases: More questions than answers
por: Cario, Elke
Publicado: (2017)

Methotrexate; a trustworthy answer to an inflammatory response in osteoarthritis
por: Mehrpoor, Golbarg, et al.
Publicado: (2022)

Patient Perspectives and Expectations in Inflammatory Bowel Disease: A Systematic Review
por: Al Khoury, Alex, et al.
Publicado: (2021)

Letter to the editor: Triclosan in patients with inflammatory bowel disease
por: Peña-Cardelles, Juan Francisco
Publicado: (2022)

Tremor in Patients with Inflammatory Bowel Disease
por: De Oliveira, Gisele R., et al.
Publicado: (2013)

The impact of biologics on health-related quality of life in patients with inflammatory bowel disease
por: Vogelaar, Lauran, et al.
Publicado: (2009)

Very Short Answer Questions: The Answer to the Perfect Medical Assessment? [Letter]
por: Janmohamed, Imran Karim, et al.
Publicado: (2019)

Truth telling and communication skills
por: Chaturvedi, S. K.
Publicado: (2009)

Therapeutic drug monitoring in inflammatory bowel disease: At the right time in the right place
por: Truta, Brindusa
Publicado: (2022)

Telling the truth to patients and relatives
por: Shamasundar, C.
Publicado: (2008)

Tell the truth, but be gentle
por: Jena, Amitabh, et al.
Publicado: (2013)

Has the time been reached for pseudopolyps to be re-enrolled in endoscopic inflammatory bowel disease scores?
por: Politis, Dimitrios S, et al.
Publicado: (2019)

Familial inflammatory bowel diseases in Northwest Greece
por: Katsanos, Konstantinos H., et al.
Publicado: (2015)

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Children and Expectant Mothers With Inflammatory Bowel Disease
por: Benchimol, Eric I, et al.
Publicado: (2021)

Immunogenicity of biologics in inflammatory bowel disease
por: Vermeire, Séverine, et al.
Publicado: (2018)

Inflammatory bowel disease induced by bimekizumab
por: Wietrzykowska-Grishanovich, Dominika, et al.
Publicado: (2022)

Life Expectancy as a Quality of Life Indicator
por: Aimbetova, Gulshara, et al.
Publicado: (2022)

Tell me where you went, I may tell who you infected
por: Guerra, Sónia Silva, et al.
Publicado: (2022)

Agenesis of vocal cords in a child diagnosed with Cornelia de Lange syndrome: Time to relook or “time will tell”
por: Rao, P. Bhaskar, et al.
Publicado: (2020)

Alterations of pulmonary function in patients with inflammatory bowel diseases
por: Al-Mendalawi, Mahmood Dhahir
Publicado: (2017)

Answer to the editor: “Factors influencing the quality of life of children with cochlear implants”
por: da Silva, Vagner Antonio Rodrigues, et al.
Publicado: (2020)

Telling time with monkeys
por: Bibi, Faysal
Publicado: (2022)

Root‐cause analyses of missed opportunities for the diagnosis of colorectal cancer in patients with inflammatory bowel disease
por: Gordon, Claire, et al.
Publicado: (2020)

Stories that Hair can Tell
por: Gude, Dilip
Publicado: (2011)

Inflammatory Bowel Disease and the Risk of Herpes Zoster
por: Lai, Shih-Wei
Publicado: (2019)

Awareness of adverse effects of Azathioprine in patients with Inflammatory Bowel Disease – more to be done?
por: Spence, Andrew David Roy, et al.
Publicado: (2014)

What forecasting the prevalence of inflammatory bowel disease may tell us about its evolution on a national scale
por: Santiago, Mafalda, et al.
Publicado: (2019)

Time to clinical response and remission for therapeutics in inflammatory bowel diseases: What should the clinician expect, what should patients be told?
por: Vasudevan, Abhinav, et al.
Publicado: (2017)

Answer to letter: dissociating advances in orthopaedic trauma management from the climbing patient expectations. “Good vs. good”—setting reasonable goals for patients’ satisfaction
por: Keppler, Lena, et al.
Publicado: (2021)

Study of life expectancy in urban Pondicherry
por: Sarkar, Sonali, et al.
Publicado: (2014)

Biologic treatment of Japanese patients with inflammatory bowel disease
por: Mahlich, Jörg, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vdn3m66564jm8sq6kbspmbirel